Does the price of adagrasib differ in different regions?

Adagrasib (Adagrasib) is an oral small molecule covalent inhibitor that irreversibly and selectively binds to KRAS G12C, trapping it in its inactive guanosine diphosphate-bound state. Adaglicib has favorable properties, including a long half-life of 23 hours, dose-dependent pharmacokinetics, and central nervous system penetration. Adagrasiib has demonstrated clinical activity and tolerability in patients with previously treated KRAS G12C-mutant non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). Adagrasiib is an oral tablet. It is usually taken twice a day, with or without food, for as long as your doctor recommends treatment.

Since the original research product of adagrasib has not yet been launched in the Chinese market and has not been included in the medical insurance system, patients currently mainly rely on overseas channels to obtain it. In the international market, the price of the original Adagraxibu is as high as hundreds of thousands of yuan, which fluctuates due to exchange rate changes. However, the latest developments show that a generic version of adagrasib has been developed and sold by Lucius Pharmaceuticals in Laos. Although the ingredients of this generic drug are basically the same as those of the original product, the price is very competitive. Each box of 90 tablets of 200 mg costs about RMB 4,000 (also affected by the exchange rate). Compared with the original drug, the price is significantly discounted.

To sum up, although adagrasib has achieved a significant breakthrough in efficacy. For patients, purchasing or choosing generic drugs overseas may be a more feasible option at present. Different regions have different listing conditions, and their prices will also vary slightly. Patients should choose formal channels when purchasing drugs. For more information on overseas drug prices and related information, consult Yaode Medical Consultant.